跳至主要内容
临床试验/NL-OMON50002
NL-OMON50002撤回不适用

Do Angiotensin Receptor BLOCKers have beneficial effect on the disease course of COVID-19 infection in high risk or elderly patients in an early phase - LOCK-COVID-19

Academisch Medisch Centrum0 个研究点目标入组 642 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
642

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age * 70 years of age or comorbidities such as chronic lung disease,
  • cardiovascular disease, any solid or haematological malignancies, diabetes,
  • hypertension, rheumatic disease, immune-deficiencies either by disease or by
  • medication use or severe obesity (BMI * 35).
  • - Fever (a temperature of * 38,0 °C) or complaints of cough with or without
  • - AND at least one of these symptoms typical for SARS-CoV-2 infection such as:
  • o nausea, vomiting and diarrhoea
  • o loss of smell and/or taste.
  • - Positive PCR test or High suspicion of a SARS-COV-2 infection because of
  • typical symptoms and the possibility that the individuals could have been
  • - Being able to give written or verbal informed consent

排除标准

  • - Suffering from (symptomatic) hypotension
  • - Registered allergy to Telmisartan.
  • - Receiving Potassium supplement.
  • - Renal failure requiring dialysis therapy or (previous) kidney transplant
  • - Known liver disease or liver insufficiency
  • - Inability to comprehend patient information due to mental impairment such as
  • - life expectancy of less than 3 months

研究者

相似试验